SCHEMBL14395652

SCHEMBL14395652

CCN(C)C(=O)Nc1nc2cc(-c3ccccc3)ccc2o1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ HDAC6 Q9UBN7 2/20 0.47
▸ NPC1 O15118 3/20 0.46
▸ RAB9A P51151 3/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ CASP3 P42574 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ SENP7 Q9BQF6 1/20 0.46
▸ DGAT1 O75907 1/20 0.45
▸ CETP P11597 1/20 0.44
▸ AGPAT2 O15120 1/20 0.44
▸ FAAH O00519 2/20 0.43
▸ IL6 P05231 1/20 0.43
▸ STAT3 P40763 1/20 0.43
▸ CHIA Q9BZP6 1/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ TP53 P04637 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14097679 0.81 ABL1 (0.59) GAAL3MBTL1HDAC6NPC1RAB9A
SCHEMBL14097676 0.80 SMN1; SMN2 (0.58) GAAL3MBTL1HDAC6NPC1RAB9A
SCHEMBL14097700 0.79 GAA (0.50) GAAL3MBTL1HDAC6NPC1RAB9A
SCHEMBL12162598 0.74 GAA (0.52) GAAL3MBTL1HDAC6NPC1RAB9A
SCHEMBL3476539 0.71 NPC1 (0.58) GAAHDAC6NPC1RAB9AMEN1
SCHEMBL14097682 0.70 ABL1 (0.60) HDAC6NPC1RAB9ASMN1; SMN2TP53
SCHEMBL22777818 0.69 GAA (0.59) GAAL3MBTL1HDAC6NPC1RAB9A
SCHEMBL29448067 0.69 GAA (0.59) GAAL3MBTL1HDAC6NPC1RAB9A
SCHEMBL3476611 0.68 FAAH (0.61) GAAL3MBTL1HDAC6NPC1RAB9A
SCHEMBL3475420 0.68 HDAC6 (0.67) GAAL3MBTL1HDAC6NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1341769-B1 BACTERIAL GYRASE INHIBITORS AND USES THEREOF VERTEX PHARMA (US) 2007-10-17 — — EP disclosed
Send feedback